Enhanced biomaterials for improved fracture healing and bone repair
Advancing the current standards of bone repair
- The bone repair of tomorrow
The proportion of elderly people is growing. As we get older, the risk of bone fractures and osteogenic diseases rise. As of now, there are no optimal solution for treating bone defects and fractures.
Bone graft is widely recognized as the gold standard, but requires doners and additional surgery, which is not not always available nor optimal. There is a great need for optimal bone graft substitutes
“All of us struggle with finding the optimal bone filler. We’re not there yet.”
“We should not only restore the defect to have a nice picture, but we should restore the healing.”
– Quotes from KOLs (orthopaedic surgeons)
There is currently no optimal bone graft substitute
No scaffold has proven great biointegration
Drug enhanced biomaterials for improved fracture healing and bone repair
Our mission and vision
To provide the best opportunity for bone healing and improved patient quality of life.
Embios develops drug-enhanced biomaterials for optimal fracture healing and bone repair.
Meet the team
Founder & CSO
Dr. Werner Hettwer
MD. PhD. | Orthopaedic Oncology Surgeon
PhD. | Serial Business Developer and Executive
PhD. | Biomedical Science
MSc. | Brand & Communications Management
Lokapriya Nandan Basavanna
MSc. | Pharmaceutical Science
Emil Funk Vangsgaard
BSc. | Biotechnology
Would you like to know more?
Go to our contact page for contact our information